Results 101 to 110 of about 1,730 (187)
Assessment of disease progression in dysferlinopathy: A 1-year cohort study [PDF]
ObjectiveTo assess the ability of functional measures to detect disease progression in dysferlinopathy over 6 months and 1 year.MethodsOne hundred ninety-three patients with dysferlinopathy were recruited to the Jain Foundation's International Clinical ...
Praxedes N. S. -A. +69 more
core +1 more source
Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism.
Background: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process ...
CENACCHI, GIOVANNA +7 more
core +1 more source
Background Dysferlinopathies are a group of autosomal recessive limb‐girdle muscular dystrophies (LGMDs) caused by mutations in DYSF (#603,009). This gene encodes a transmembrane protein called dysferlin.
Marzieh Mojbafan +5 more
doaj +1 more source
Diagnosis of Dysferlinopathies [PDF]
openaire +1 more source
Dysferlinopathies: phenotypic study of a Moroccan series of 28 cases. [PDF]
Mouloudi N +3 more
europepmc +1 more source
Peptide-phosphorodiamidate morpholino oligomer therapy for dysferlinopathy induces pseudoexon skipping and restoration of functional protein. [PDF]
Gooding JE +5 more
europepmc +1 more source
Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy. [PDF]
Kang S +9 more
europepmc +1 more source
Muscle RING finger-1 facilitates skeletal muscle regeneration via regulating myoblast proliferation and differentiation. [PDF]
Yang M +10 more
europepmc +1 more source
<i>DYSF </i>gene variant spectrum in Arab populations across eight countries: A systematic review. [PDF]
Smaili F, Zerrouki K, Aouni FE, Tajir M.
europepmc +1 more source

